Company intelligence / Profile preview

Låkril Technologies

Chicago, Illinois, United States

Ownership: Private
Development stage: Preclinical

Overview

Låkril Technologies has developed and is scaling the "Låkril Amber Process," which enables the production of bio-based, sustainable acrylic acid and acrylate derivatives from renewable feedstocks such as corn-derived sugars. This process offers drop-in replacements for petrochemical-derived products in paints, coatings, adhesives, and superabsorbents at cost parity. The company is currently scaling up to enable production at approximately 50,000 metric tons per year. No clinical results are relevant.

Industry: Non-Drug Biotech

Partnerships

U.S. Department of EnergyNational Science Foundation Center for Sustainable Polymers / University of Minnesota collaboration

Beyond the preview

Go deeper on Låkril Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Låkril Technologies.

Explore the full profile